Philip F. Halloran

University of Alberta — Canada

Medicine · Health Sciences

105h-index47.9kcitations683works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Transplantation Outcomes and Treatments(346), Organ Transplantation Techniques and Outcomes(150), Transplantation: Methods and Outcomes(139), Renal Diseases and Glomerulopathies(81), Organ Donation and Transplantation(65)

Publications681 total

Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection
Nature Communications·2026Open Access
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection
Nature Communications·2025· 4 citedOpen Access
Molecular biopsy features associated with baseline lung allograft dysfunction in a multicenter international cohort
The Journal of Heart and Lung Transplantation·2025· 1 cited
From the Bench to the Bedside and Back: Contemporary Applications of Basic Science to Innovations in Heart Transplantation
Canadian Journal of Cardiology·2025
#512 Monitoring anti-CD38 treatment with felzartamab in antibody-mediated kidney allograft rejection
Nephrology Dialysis Transplantation·2025Open Access
#604 Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies
Nephrology Dialysis Transplantation·2025
Epithelial Injury Cell States Affect Kidney Transplant Survival After T Cell-Mediated Rejection
Journal of the American Society of Nephrology·2025
Archetypal analysis of deceased donor kidneys: A molecular approach for posttransplant outcomes
American Journal of Transplantation·2025Open Access
The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection
Kidney International Reports·2025Open Access
Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
American Journal of Transplantation·2025· 4 citedOpen Access
Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes
American Journal of Transplantation·2025
T Cell-Mediated Rejection Produces Unique Patterns of Molecular Injury: An Underestimated Menace
American Journal of Transplantation·2025
Calling All DSA Positive Allows Existing Banff Guidelines to Diagnose Many More Cases of Histologic ABMR Currently Missed Only Because They Are DSA-Negative
American Journal of Transplantation·2025
Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients
American Journal of Transplantation·2025Open Access
Trial Design of the Phase 2 Study SHAMROCK Evaluating the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Kidney Transplant Recipients with Antibody-Mediated Rejection
American Journal of Transplantation·2025Open Access
Trifecta-Lung Study: dd-cfDNA Correlates with T Cell-Mediated Rejection and Parenchymal Injury in Mucosal Biopsies of Lung Transplants
American Journal of Transplantation·2025
Flower dependent trafficking of lamellar bodies facilitates maturation of the epidermal barrier
Nature Communications·2025· 2 citedOpen Access
Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection
Kidney International Reports·2025· 3 citedOpen Access
Targeting CD38 in Antibody-Mediated Rejection
Transplant International·2025· 6 citedOpen Access
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies
Nature Medicine·2025· 20 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Kim Solez(15), B. Sis(14), Michael Mengel(13), Gunilla Einecke(10), Luis Hidalgo(10), J. Reeve(9), Lorraine C. Racusen(8), Robert B. Colvin(7), Denis Glotz(7), Roslyn B. Mannon(6), Daniel Serón(6), Jacobo Sellarés(6), Konrad S. Famulski(6), Patricia Campbell(6), Ian W. Gibson(5), Mark Haas(5), Volker Nickeleit(5), Parmjeet Randhawa(5), Arthur J. Matas(5), Anthony J. Demetris(4)